Investment Rating - The report maintains a "Buy" rating for several companies in the AI and computing sector, including 亿道信息 (001314.SZ), 唯科科技 (301196.SZ), 能科科技 (603859.SH), 嘉和美康 (688246.SH), 合合信息 (688615.SH), and 迈信林 (688685.SH) [11]. Core Insights - Qualcomm launched AI inference chips AI200 and AI250, focusing on low power consumption and high cost-effectiveness, aiming to challenge NVIDIA's dominance in the AI chip market [4][17]. - NVIDIA's GTC conference showcased its strategic vision for AI, including advancements in next-generation chip architecture, 6G communication, quantum computing, and AI infrastructure [5][27]. - AI data annotation platform Mercor completed a $350 million Series C funding round, significantly increasing its valuation and aiming to democratize high-paying knowledge work [46][48]. Summary by Sections Computing Power Dynamics - The rental prices for computing power remain stable, with specific pricing for cloud services noted [16]. - Qualcomm's AI chips are designed for data centers, featuring a unique memory architecture and modular deployment, which could reshape the competitive landscape in data center computing [17][19]. AI Application Dynamics - Perplexity's weekly traffic increased by 5.73%, indicating growing interest in AI applications [5][26]. - NVIDIA's GTC conference highlighted its comprehensive strategy for AI, addressing challenges in the computing industry and presenting solutions through parallel computing and GPU integration [29][30]. AI Financing Trends - Mercor's recent funding round reflects a growing market for AI data annotation services, with plans to expand into healthcare and legal sectors [46][48]. - The competitive landscape for AI platforms is evolving, with Mercor positioning itself as a leader in high-value expert tasks [47]. Market Performance Review - The AI application index and AI computing index showed varying performance, with notable gains and losses among specific companies [52][58]. Investment Recommendations - The report suggests focusing on companies with successful clinical AI product validations and those expanding their computing power capabilities, such as 嘉和美康 (688246.SH) and 迈信林 (688685.SH) [60].